{"id":11913,"date":"2020-03-06T07:12:29","date_gmt":"2020-03-06T12:12:29","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=11913"},"modified":"2020-03-06T07:12:29","modified_gmt":"2020-03-06T12:12:29","slug":"new-filings-updated-terms-ending-3-6-20am","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/new-filings-updated-terms-ending-3-6-20am\/","title":{"rendered":"New Filings &#038; Updated Terms (ending 3.6.20am)"},"content":{"rendered":"<p><!--more--><\/p>\n<p>NEW FILINGS<\/p>\n<p>Company: Pulmonx Corporation<br \/>\nSymbol: LUNG<br \/>\nDescription: They are a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD).<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nTrade Date: TBD<br \/>\nUnderwriter(s): BofA Securities, Morgan Stanley<br \/>\nCo-Manager(s): Stifel, Wells Fargo Securities, Canaccord Genuity<br \/>\nFiled: 2-28-20<br \/>\nListed Cash Raise: $86.25m<\/p>\n<p>Company: Accolade Inc.<br \/>\nSymbol: ACCD<br \/>\nDescription: They provide personalized, technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits.<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nTrade Date: TBD<br \/>\nUnderwriter(s): Goldman Sachs, Morgan Stanley, BofA Securities, Piper Sandler, Credit Suisse<br \/>\nCo-Manager(s): William Blair, Baird, SVB Leerink<br \/>\nFiled: 2-28-20<br \/>\nListed Cash Raise: $100m<\/p>\n<p>Company: Oric Pharmaceuticals Inc.<br \/>\nSymbol: ORIC<br \/>\nDescription: They are a clinical-stage biopharmaceutical company dedicated to improving patients\u2019 lives by Overcoming Resistance In Cancer.<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nTrade Date: TBD<br \/>\nUnderwriter(s): J.P. Morgan, Citigroup, Jefferies, Guggenheim Securities<br \/>\nFiled: 2-28-20<br \/>\nListed Cash Raise: $86.25mimara<\/p>\n<p>Company: Procore Technologies Inc.<br \/>\nSymbol: PCOR<br \/>\nDescription: They are a leading provider of cloud-based construction management software, and are helping transform one of the oldest, largest, and least digitized industries in the world.<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nTrade Date: TBD<br \/>\nUnderwriter(s): Goldman Sachs, J.P. Morgan, Barclays, Jefferies<br \/>\nCo-Manager(s): Canaccord Genuity, KeyBanc Capital, Oppenheimer, Piper Sandler, Stifel, William Blair<br \/>\nFiled: 2-28-20<br \/>\nListed Cash Raise: $100m<\/p>\n<p>TERMS ADDED<\/p>\n<p>Company: Imara Corp<br \/>\nSymbol: IMRA<br \/>\nDescription: They are a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapeutics to treat patients suffering from rare inherited genetic disorders of hemoglobin, known as hemoglobinopathies.<br \/>\nShares: 4.45 million<br \/>\nPrice Range: $16.00-$18.00<br \/>\nMarket Cap: $261m-$294m<br \/>\nTrade Date: Thursday, March 12<br \/>\nUnderwriter(s): Morgan Stanley, Citigroup, SVB Leerink<br \/>\nTerms Added: 3-3-20<\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[24,1536],"tags":[],"class_list":["post-11913","post","type-post","status-publish","format-standard","hentry","category-ipo","category-subscriber-content"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/11913","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=11913"}],"version-history":[{"count":1,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/11913\/revisions"}],"predecessor-version":[{"id":11914,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/11913\/revisions\/11914"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=11913"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=11913"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=11913"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}